Alpha Tau Medical (DRTS) Earnings Analysis
Alpha Tau Medical (DRTS) next reports earnings on 2026-08-10, consensus EPS -0.14 USD. Last quarter (2026-05-18) it missed with EPS -0.26 USD vs -0.13 USD est (-100%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -19.42.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does DRTS next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.14 USD |
| Revenue estimate | 0.00B |
DRTS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | -0.26 USD | -0.13 USD | -100% | Miss |
| 2026-03-09 | -0.14 USD | -0.13 USD | -7.7% | Miss |
| 2025-11-20 | -0.14 USD | -0.12 USD | -16.7% | Miss |
| 2025-08-11 | -0.13 USD | -0.12 USD | -8.3% | Miss |
| 2025-05-19 | -0.12 USD | -0.14 USD | +14.3% | Beat |
| 2025-03-12 | -0.13 USD | -0.13 USD | 0% | Beat |
| 2024-08-14 | -0.11 USD | -0.13 USD | +15.4% | Beat |
Beat rate: 3/7 (43%) over reported quarters with consensus data.
DRTS valuation and analyst view
| Trailing P/E | -19.42 |
|---|---|
| Trailing EPS | -0.63402 USD |
| Price / book | 16.83 |
| Dividend yield | 0.00% |
| Market cap | 1.18B |
| Analyst consensus | Buy (5 buy / 1 hold / 0 sell) |
| Avg price target | 13.75 USD |
Related research pages
Frequently asked questions
When is Alpha Tau Medical (DRTS)'s next earnings date?
Alpha Tau Medical is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.14 USD and revenue estimate of 0.00B.
Did DRTS beat earnings last quarter?
In its 2026-05-18 report, DRTS posted EPS of -0.26 USD versus a -0.13 USD estimate — a miss of 100%.
What is DRTS's earnings track record?
Over the last 7 reported quarters with consensus data, DRTS beat estimates 3 times (43%).
What is DRTS's current P/E ratio and EPS?
DRTS trades at a trailing P/E of -19.42 on trailing EPS of -0.6340198662084868 USD.
What do analysts rate DRTS?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 13.75 USD.